Catalyst Pharmaceuticals
CPRX
#3579
Rank
S$4.97 B
Marketcap
S$40.66
Share price
0.00%
Change (1 day)
53.45%
Change (1 year)

EPS for Catalyst Pharmaceuticals (CPRX)

EPS in 2026 (TTM): S$2.32

According to Catalyst Pharmaceuticals's latest financial reports the company's current EPS (TTM) is S$2.34. In 2025 the company made an earnings per share (EPS) of S$2.27 an increase over its 2024 EPS that were of S$1.79.

EPS history for Catalyst Pharmaceuticals from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$2.322.14%
2025S$2.2726.62%
2024S$1.79
2022S$1.03110.53%
2021S$0.49-47.22%
2020S$0.93132.26%
2019S$0.40-191.18%
2018S-$0.4454.55%
2017S-$0.28-4.35%
2016S-$0.30-8%
2015S-$0.32

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$8.63 269.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$0.92-60.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$3.49 49.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
S-$3.40-245.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
S-$64.96-2,879.56%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S-$0.12-104.97%๐Ÿ‡บ๐Ÿ‡ธ USA